FDA Inspection
Michael M. Dao, M.D.Michael M. Dao, M.D. – FDA Inspection, May 16, 2014
Record Details
This FDA Inspection record concerns Michael M. Dao, M.D., with an inspection on May 16, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Michael M. Dao, M.D.
- Inspection Date
- May 16, 2014
- Product Type
- Drugs
View Company Profile
ID · 1cc13f76-1e32-4910-8b48-48cfc2b7d73c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 881983
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
6- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.66Initial and continuing review
- 21 CFR 312.60Informed consent
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.62(a)Accountability records
- 21 CFR 50.20Consent not obtained, exceptions do not apply
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Michael M. Dao, M.D.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| July 18, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 18, 2013 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Michael M. Dao, M.D.
- FDA Inspection 1103474 - 2019-07-18
- FDA Inspection 814431 - 2013-01-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.